SCHEDULE 13D/A Filed 2026-07-27 Event 2026-07-23 SEC 0001214659-26-009076 →

TANG CAPITAL MANAGEMENT LLC → Nano Dimension Ltd. NNDM

Stake: — Shares: 16,715,812 Class: Ordinary Shares par value NIS 5.00 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 47/100 · Filer 90d Win Rate: 100% · Hist. 90d Edge: +0.5%

Filer track record (3 filings): 100% 90d win rate, +0.5% 90d edge
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (6.5 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

11 13D/G filings on this issuer

10 other filings besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 6.50

9,688,911 shares short · +1.5% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $40K

Point72 Asset Mgmt

Other 13D/G Filings on Nano Dimension Ltd.

Filed	Form	Filer	Stake	Shares
2026-07-22	SCHEDULE 13D/A	ORAMED PHARMACEUTICALS INC.	—	6,879,708	view →
2026-07-20	SCHEDULE 13D/A	Murchinson Ltd.	—	17,136,276	view →
2026-06-30	SCHEDULE 13D	TANG CAPITAL MANAGEMENT LLC	—	14,292,813	view →
2026-06-23	SCHEDULE 13D/A	Murchinson Ltd.	—	20,285,450	view →
2026-06-17	SCHEDULE 13D/A	ORAMED PHARMACEUTICALS INC.	7.20%	15,079,708	view →
2026-05-21	SCHEDULE 13D/A	Murchinson Ltd.	7.40%	15,550,000	view →
2023-10-27	SC	Murchinson Ltd.	—	—	view →
2023-05-02	SC	Anson Funds Management LP	—	—	view →
2023-05-02	SC	Murchinson Ltd.	—	—	view →
2021-12-14	SC	STERN YOAV	—	—	view →

Other Filings by TANG CAPITAL MANAGEMENT LLC

Filed	Form	Issuer	Stake	Shares
2026-10-06	SCHEDULE 13G	Atea Pharmaceuticals, Inc.	—	—	view →
2026-06-30	SCHEDULE 13D	Nano Dimension Ltd. NNDM	—	14,292,813	view →
2026-06-29	SCHEDULE 13G	Boundless Bio, Inc. BOLD	—	—	view →
2026-06-10	SCHEDULE 13G	Fulcrum Therapeutics, Inc. FULC	—	—	view →
2026-06-04	SCHEDULE 13D/A	Aurinia Pharmaceuticals Inc. AUPH	10.00%	13,044,106	view →
2026-05-13	SCHEDULE 13D/A	Kezar Life Sciences, Inc.	—	0	view →
2025-09-03	SCHEDULE	iTeos Therapeutics, Inc.	100.00%	10,000	view →
2025-05-19	SCHEDULE	Allakos Inc.	100.00%	10,000	view →
2025-04-03	SCHEDULE	Allakos Inc.	9.60%	8,693,687	view →
2025-03-04	SCHEDULE	Aurinia Pharmaceuticals Inc. AUPH	7.30%	10,029,500	view →
2025-02-27	SCHEDULE	ACELYRIN, Inc.	7.30%	7,298,328	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →